Correction to company announcement in English: The English company announcement regarding the report for the first three quarters of 2025 incorrectly included figures from the half year. This announcement has now been updated with the correct figures of the first three quarters of 2025.
VANCOUVER, British Columbia and BOSTON, MA, April 19, 2026 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development and commercialization of life-changing therapeutics for patients in need, today presented positive data from the Phase 3 X-TOLE2 study highlighting the efficacy and safety of azetukalner in focal…
NEW YORK, April 19, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Pinterest, Inc. (NYSE: PINS) between February 7, 2025 and February 12, 2026, inclusive, (the “Class Period”), of the important May 29, 2026 lead plaintiff deadline.
NEW YORK, April 19, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Coty Inc. (NYSE: COTY) and certain of its officers.
EDMONTON, Alberta , April 19, 2026 (GLOBE NEWSWIRE) -- Fedora Pharmaceuticals, Inc., a leader in the development of drugs to treat antibiotic-resistant infections, is presenting a full suite of preclinical findings from the company’s lead candidate, FPI-2119 at the European Society of Clinical Microbiology and Infectious Diseases Congress (ESCMID) in Munich, Germany. Presentations at ESCMID…
PARIS, April 19, 2026 (GLOBE NEWSWIRE) -- From April 15–16, 2026, one of Europe’s premier blockchain events, Paris Blockchain Week 2026, concluded in Paris, France. Under the theme “The Bridge Between TradFi and Digital Assets,” the conference brought together regulators, financial institutions, Web3 projects, and infrastructure providers to explore the convergence of digital assets and…
